Fresh Data Show Toll South African Virus Variant Takes on Vaccine Efficacy Fresh Data Show Toll South African Virus Variant Takes on Vaccine Efficacy
Clinical trial data on two COVID-19 vaccines show that a coronavirus variant first identified in South Africa is lessening their ability to protect against the illness, underscoring the need to vaccinate vast numbers of people as quickly as possible, scientists said.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: African Health | Clinical Trials | Coronavirus | COVID-19 | Infectious Diseases | Intensive Care | South Africa Health | Vaccines